Efficacy, Safety and Pharmacokinetics of BCD-100 (Anti-PD-1) Monotherapy as Second Line Treatment in Patients With Non-Small Cell Lung Cancer (DOMINUS) — DOMINUS

Non-Small Cell Carcinoma of Lung, TNM Stage 4 Clinical Trial

Official title:
International Multi-center Open-label Randomized Clinical Trial of Efficacy, Safety and Pharmacokinetics of BCD-100 (JSC "BIOCAD", Russia) Monotherapy Compared to Docetaxel as Second-line Therapy of Patients With Advanced Inoperable or Metastatic Non-small Cell Lung Cancer

Status Active, not recruiting

Clinical Trial Summary

International multi-center open-label randomized clinical trial of efficacy, safety and pharmacokinetics of BCD-100 (JSC BIOCAD, Russia) monotherapy compared to docetaxel as second-line therapy of patients with advanced inoperable or metastatic non-small cell lung cancer

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Carcinoma, Non-Small-Cell Lung
Lung Neoplasms
Non Small Cell Lung Cancer Stage IIIB
Non-Small Cell Carcinoma of Lung, TNM Stage 4

Clinical Trial Details

NCT number	NCT03288870
Study type	Interventional
Source	Biocad
Contact
Status	Active, not recruiting
Phase	Phase 2/Phase 3
Start date	September 19, 2017
Completion date	August 10, 2021

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT03786692` - Phase II Randomized Trial of Carboplatin+Pemetrexed+Bevacizumab+/- Atezolizumab in Stage IV NSCLC	Phase 2
Completed	`NCT04776083` - Radiotherapy to the Primary in Metastatic Non-small Cell Lung Cancer Patients	Phase 3
Recruiting	`NCT05919264` - FOG-001 in Locally Advanced or Metastatic Solid Tumors	Phase 1/Phase 2
Recruiting	`NCT03042221` - Early Rebiopsy to Identify Biomarkers of Tumor Cell Survival Following EGFR, ALK, ROS1 or BRAF TKI Therapy
Recruiting	`NCT05274451` - A Study to Investigate LYL797 in Adults With Solid Tumors	Phase 1
Recruiting	`NCT05372081` - Clinical and Molecular Study With Digital Support of Patients With Inoperable Lung Cancer
Recruiting	`NCT03774732` - PD-1 Inhibitor and Chemotherapy With Concurrent Irradiation at Varied Tumour Sites in Advanced Non-small Cell Lung Cancer	Phase 3
Completed	`NCT03406468` - Re-Induction After Initial Response With Immune Therapy With Radiotherapy in Lung Cancer	Phase 2
Recruiting	`NCT04856176` - A Study of Sargramostim Plus Pembrolizumab With or Without Pemetrexed in Patients With Advance Non-small Cell Lung Cancer After Completion of Chemoimmunotherapy	Phase 2
Completed	`NCT04710459` - Endobronchial Cryotherapy in Management of MEBO in Patients With Inoperable NSCLC	N/A
Terminated	`NCT02967133` - A Study of Nivolumab +/- Nab-paclitaxel in Non-small Cell Lung Cancer	Phase 2
Recruiting	`NCT03605602` - A Real World Study Based on NGS (TRUMPRWS)